Related Experiment Video
Updated: Apr 18, 2026
06:38
The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo
Published on: December 19, 2025
430
C1 inhibitor deficiency: 2014 United Kingdom consensus document.
H J Longhurst1, M D Tarzi2, F Ashworth3
1Department of Immunology, Barts Health NHS Trust and Medical Adviser HAE, UK.
Clinical and Experimental Immunology
|January 22, 2015
Summary
This updated UK consensus provides 48 recommendations for managing C1 inhibitor deficiency, a rare cause of hereditary angioedema. The guidelines emphasize improved acute treatment, home therapy, and service organization for better patient care.
Area of Science:
- Immunology
- Genetics
- Rare Diseases
Background:
- C1 inhibitor deficiency is a rare genetic disorder causing recurrent angioedema attacks.
- Effective management is crucial due to the potentially life-threatening nature of attacks.
- Previous guidelines required updating to reflect current clinical understanding and practice.
